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Abstract
Background: Transient elastography (TE) is an innovative, noninvasive technique to assess liver fibrosis by
measuring liver stiffness in patients with chronic liver diseases. The purpose of this study has been to explore the
accuracy of TE and clinical parameters in predicting the presence of esophageal/gastric varices in children with
biliary atresia (BA) following portoenterostomy.
Methods: Patients with BA status post portoenterostomy and normal children were recruited. Splenomegaly and
presence of EV/GV were determined by physical examination and endoscopy, respectively. Aspartate transaminase
to platelet ratio index (APRI) was used as a serum fibrosis marker. TE was performed by using FibroScan. Data was
expressed as mean ± SD.
Results: Seventy-three BA patients (male:female = 32:41; age 9.11 ± 5.64 years) and 50 normal controls (male:
female = 19:31; age 11.00 ± 3.31 years) were enrolled. The liver stiffness score of BA patients was significantly
higher than that of normal controls (27.37 ± 22.48 and 4.69 ± 1.03 kPa; p < 0.001). Patients with EV/GV had
significantly higher liver stiffness score and APRI than those without EV/GV. As for EV/GV diagnosis, the areas under
the receiver operating characteristic curve were 0.89 (95% CI 0.80 to 0.98) for TE and 0.87 (95% CI 0.78 to 0.96) for
APRI, respectively. The sensitivity (and specificity) of TE (using a cut-off value of 12.7 kPa) and APRI (using a cut-off
value of 1.92) in predicting EV/GV were 84% (77%) and 84% (83%), respectively, whereas the sensitivity (and
specificity) of splenomegaly in predicting EV/GV were 92% (85%).
Conclusions: Transient elastography is a useful tool for predicting the presence of EV/GV. In addition, basic
physical examination, routine biochemical and hematological tests, are still worthwhile and correlate well with the
presence of EV/GV in patients with BA post portoenterostomy.
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Background
Biliary atresia (BA) is a progressive, idiopathic, necroin-
flammatory process resulting in obliteration of the extra-
hepatic biliary tree. It is the most common cause of
neonatal jaundice for which surgery is indicated and also
the most common indication for liver transplantation in
children. The pathogenesis of BA has remained a mystery.
Most of the causal theories include defects resulting from
a viral infection or toxin exposure, defects in morphogen-
esis, genetic predisposition, defects in prenatal circulation,
and immune dysregulation [1]. The obstruction of bile
flow results in worsening cholestasis, liver fibrosis, and
cirrhosis, which lead to portal hypertension and a decline
in hepatic synthetic function. Successful restoration of bile
flow by portoenterostomy can be accomplished in 60 to
90% of patients, although 75% of them will progress to
cirrhosis and eventually end-stage liver disease requiring
liver transplantation [2]. Progression of liver disease
following portoenterostomy is thought to be partly related
to repeated attacks of cholangitis.
Liver fibrosis leads to development of portal hyperten-
sion and subsequent complications including ruptured
esophageal and/or gastric varices (EV/GV), splenomegaly,
and ascites. Bleeding from ruptured EV/GV can be fatal.
Consequently, monitoring of the presence of EV/GV is
useful for the commencement of prophylactic treatment.
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endoscopy which is considered an invasive procedure in
children.
The current gold standard for diagnosing liver fibrosis
and cirrhosis is histological analysis of tissue obtained
through liver biopsy. Nonetheless, even with sonography
guidance, it still causes major complications such as
bleeding requiring surgery, bile leak, visceral perforation
or arteriobiliary fistula [3-6]. Furthermore it has some
limitations including sampling errors along with intra-
observer and inter-observer variation [7,8]. In recent
years, efforts have been dedicated to the development of
non-invasive tests to replace liver biopsy for fibrosis
assessment and follow-up. Those tests include imaging,
serum marker panels such as Fibrotest and aspartate
transaminase to platelet ratio index (APRI), and last but
not least, transient elastography [9-11].
Transient elastography (FibroScan) is an innovative,
noninvasive, rapid, and reproducible technique to assess
liver fibrosis by measuring liver stiffness in both adult
and pediatric patients [12,13]. The principle of the appa-
ratus is employment of pulse-echo ultrasound acquisi-
tion to track the propagation of the shear wave and to
measure its velocity. The relation between the velocity
and the tissue stiffness is that the stiffer the tissue, the
faster the shear wave propagates [14]. Transient elasto-
graphy has low intra- and inter-observer variability [15].
However, the data on liver stiffness measurement in
children with chronic liver diseases is still limited.
The purpose of this study has been to evaluate the
accuracy of transient elastography and clinical para-
meters in predicting the presence of EV/GV in children
with BA following portoenterostomy.
Methods
Children with BA who had undergone Kasai portoen-
terostomy at King Chulalongkorn Memorial Hospital
were enrolled. A palpable spleen below the costal mar-
gin on physical examination (supine palpation) was
considered splenomegaly. Presence of EV/GV was
demonstrated by fiberoptic upper gastrointestinal
endoscopic examination. Aspartate transaminase to
platelet ratio index (APRI) was calculated as follows:
AST (×40) × 100/platelet count (10
9/L) [11].
Transient elastography was performed by a well-
trained nurse using FibroScan 502 (Echosens, Paris,
France). The measurements were performed by placing
an ultrasound transducer probe of FibroScan on the
intercostal space at the area of the right liver lobe with
patients lying in a supine position with maximal abduc-
tion of the right arm. Probes with an external diameter
of 5 mm and 9 mm were used in subjects with thoracic
perimeters of ≤ 75 cm and 45-110 cm, respectively. The
measurements were carried out until 10 validated results
had been obtained with a success rate of at least 90%.
The median value of 10 validated scores was considered
the elastic modulus of the liver, and it was expressed in
kilopascals (kPa). All subjects undergoing liver stiffness
measurements had to be free from acute febrile illness.
This study was approved by the Ethics Committee,
Faculty of Medicine, Chulalongkorn University. Writ-
ten informed consent was obtained from the patients’
guardians.
Continuous data were expressed as mean ± SD. Stu-
dent’s t-test and Chi square test were used to evaluate
statistical significance of differences between groups.
Receiver operating characteristic (ROC) curves were
used to determine the reliability of the liver stiffness
score and APRI for predicting the presence of EV/GV
in postoperative patients withB A .S t a t i s t i c a la n a l y s e s
were performed using SPSS version 17.0 software
(SPSS Inc, Chicago, IL). A p value below 0.05 was con-
sidered statistically significant.
Results
Seventy-three BA patients (male:female = 32:41; age 9.11 ±
5.64 years) and 50 normal controls (male:female = 19:31;
age 11.00 ± 3.31 years) were enrolled. BMI of BA patients
was significantly lower than that of controls (17.69 ± 3.18
and 19.19 ± 3.79 kg/m
2; p = 0.03). The liver stiffness score
of BA patients was significantly higher than that of normal
controls (27.37 ± 22.48 and 4.69 ± 1.03 kPa; p < 0.001).
There were 39 patients with splenomegaly and 39 with
EV/GV. Patients with EV/GV had significantly higher liver
stiffness score and APRI than those without EV/GV
(Table 1). Patients with splenomegaly also had significantly
higher liver stiffness score than those without splenome-
galy (38.88 ± 21.95 and 9.91 ± 5.95 kPa; p < 0.001).
The diagnostic performance of Fibroscan, APRI, and the
presence of splenomegaly for detection of EV/GV was
shown in Table 2. As for EV/GV diagnosis, the areas
under the receiver operating characteristic curve were 0.89
(95% CI 0.80 to 0.98) for FibroScan and 0.87 (95% CI 0.78
to 0.96) for APRI, respectively (Figure 1). The sensitivity
(and specificity) of FibroScan (using a cut-off value of 12.7
kPa) and APRI (using a cut-off value of 1.92) in predicting
EV/GV were 84% (77%) and 84% (83%), respectively
whereas the sensitivity (and specificity) of splenomegaly in
predicting EV/GV were 92% (85%).
Discussion
Patients with biliary atresia even after successful portoen-
terostomy may suffer from complications such as rup-
tured EV/GV which can be life threatening. A recent
study has revealed that more than 50% of children with
biliary atresia below the age of 2 years developed esopha-
geal varices [16]. In addition, ectopic varices and portal
hypertensive vasculopathy (eg, portal hypertensive
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cause bleeding in patients with cirrhosis and portal
hypertension.
Transient elastography is a reproducible test both in
adults and children. Normal liver stiffness in normal adults
is reported to be in the range of 4-6 kPa which is similar
to that of normal children in this study [15]. Kazemi et al
have shown that in adult patients with cirrhosis, the opti-
mal cut-off value of the liver stiffness score for the diagno-
sis of esophageal varices is 13.9 kPa [17]. Furthermore,
liver stiffness score of ≥13.6 kPa in adults with HCV-
related cirrhosis is related to the presence of EV/GV
w h i c hi sa l s oc o m p a r a b l et ot h ef i g u r eo f1 2 . 7k P ai nt h e
present study [18]. de Lédinghen V et al have evaluated
liver stiffness measurementi nc h i l d r e nw i t hv a r i o u s
chronic liver diseases and found that transient elastogra-
phy was correlated with the presence of esophageal varices
and Metavir fibrosis score [12]. Chang et al also demon-
strated that liver stiffness scores correlated well with the
presence of esophageal or gastric varices in children with
biliary atresia following portoenterostomy [19]. Increasing
evidence has indicated that liver stiffness in children is
related to liver fibrosis and its measurement is feasible.
Liver stiffness measurement may represent a noninvasive
alternative diagnostic tool to detect complications of portal
hypertension in children with cirrhosis.
Screening for the presence of EV/GV by endoscopy is
useful for considering prophylactic therapy to prevent
bleeding, such as b-blockers to reduce portal pressure.
Current guidelines recommend screening of all cirrhotic
patients by endoscopy to estimate the risk of bleeding
[20]. Unfortunately, thrombocytopenia is a common and
challenging clinical disorder in patients with portal hyper-
tension. It can increase the risk of bleeding associated with
invasive procedures, for instance endoscopy. Standard
therapy for thrombocytopenia typically consists of platelet
transfusions, which may cause transfusion-related compli-
cations including viral or bacterial infection, alloimmuni-
zation, and febrile non-hemolytic reactions, which may
occur in up to 30% of patients undergoing platelet transfu-
s i o n s[ 2 1 ] .T h i ss t u d yh a sd e m o n s t r a t e dt h a tt r a n s i e n t
elastography is a helpful tool for predicting the presence
of EV/GV. A recent report has shown that a high liver
stiffness score in cirrhotic patients is significantly asso-
ciated with portal hypertensive enteropathy besides EV/
GV [22]. The substitution of transient elastography for
endoscopy in children has several benefits in terms of
avoiding the cost and complications of transfusion as well
as the risk of general anesthesia or sedation during under-
going endoscopy. However, further large-scale studies are
required to determine a liver stiffness cut-off value using
transient elastography for best prediction of varices
formation.
Table 1 Comparison of liver stiffness score, aspartate transaminase to platelet ratio index (APRI), presence of
splenomegaly, and platelet count between patients with and without esophageal and/or gastric varices
Patients with esophageal and/or gastric
varices
Patients without esophageal and/or gastric
varices
P
value
Liver stiffness score (kPa) 37.72 ± 21.55 10.97 ± 8.71 <0.001
APRI 6.59 ± 4.73 1.41 ± 1.25 <0.001
Presence of splenomegaly
(no.)
36 3 <0.001
Platelet count (×10
3/μL) 119.92 ± 85.23 220.74 ± 90.43 <0.001
Table 2 Performance of non-invasive markers for
prediction of esophageal/gastric varices
Splenomegaly APRI Fibroscan
Cut-off - 1.92 12.7
Sensitivity (%) 92 84 84
Specificity (%) 85 83 77
PPV (%) 88 85 81
NPV (%) 91 83 81
Accuracy (%) 89 84 83
LR+ 6.15 5.08 4.23
LR- 0.09 0.18 0.19
AUC - 0.87 0.89
95% CI 0.85-0.99 0.78-0.96 0.80-0.98
APRI, AST-to-platelet ratio index; PPV, positive predictive value; NPV, negative
predictive value; LR+, likelihood ratio for positive results; LR-, likelihood ratio
for negative results; AUC, area under the curve; CI, confidence interval.
Figure 1 ROC curve of FibroScan and aspartate transaminase
to platelet ratio index (APRI) for diagnosis of esophageal and/
or gastric varices.
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can also cause difficulties in measuring liver stiffness
[23]. In the present study, five children in the control
group were overweight (BMI > 25 kg/m
2), but liver stiff-
ness values were obtained without difficulty. Recently, it
has been demonstrated that liver stiffness measurement
is erratic for detecting fibrosis in patients with acute
hepatitis [24,25]. The reasons underlying the high stiff-
ness in acute liver damage are supposed to be related to
hepatocyte swelling, cholestasis, or inflammatory cell
infiltration in the acutely inflamed liver. In this study,
this error was negligible. No subjects had acute febrile ill-
ness and thus, should not have acute cholangitis or viral
infection which might cause acute liver damage.
The present study has also demonstrated that physical
examination and hematological tests were well correlated
with the presence of EV/GV. Fagundes et al observed
that splenomegaly was useful as a screening test to pre-
dict the presence of EV [26]. Although the presence of
splenomegaly may depend on the examiner’s individual
decision, our data have reinforced the importance of phy-
sical examination in children. A recent study demon-
strated that APRI correctly diagnosed the presence of EV
in 66% of adult cirrhotic patients [27]. A study in chil-
dren with liver diseases revealed that at a cut-off score of
1.5, APRI detected the presence of EV in 67% of patients
compared to 87% in the present study (data not shown)
[28]. A recent large-scale study on adult cirrhotic patients
revealed that a combination of non-invasive markers
(Lok index and Forns’ index) yielded an excellent nega-
tive predictive value (NPV) of over 90% to exclude clini-
cally significant esophageal varice [29]. Our data showed
that the presence of splenomegaly, APRI, and transient
elastography also obtained a high NPV (80-90%) to
exclude the presence of EV/GV in children with BA.
These data emphasize the benefit of noninvasive tests in
avoiding endoscopy in low risk cirrhotic patients.
Conclusions
Transient elastography might be a new noninvasive, inex-
pensive method for detecting the presence of EV/GV in
children with BA. In addition, basic physical examination,
routine biochemical and hematological tests, are still
worthwhile and correlate well with the presence of EV/
GV in patients with BA post portoenterostomy.
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